Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

131 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Marc Funk to transition to Recipharm's Board of Directors, Greg Behar appointed new CEO, Inhaled Business to standalone in 2024
AQ
LONZA GROUP : A sudden departure
Alphavalue
PrimeStone Capital LLC Candidates for Brenntag Board Gets Support
CI
Brenntag Annual General Meeting: All motions proposed by company have been approved with high rates
PU
Brenntag: Supervisory Board Chairwoman promotes continuity - Group candidates elected
DP
Brenntag : statement on Glass Lewis’ voting recommendation dated 31 May 2023
PU
Brenntag SE’s statement on Glass Lewis’ voting recommendation dated 31 May 2023
PU
Headwinds growing for Brenntag ahead of annual general meeting
DP
PrimeStone Capital Sends Letter to Shareholders of Brenntag SE
CI
Shareholder advisor ISS opposes Brenntag candidate for supervisory board
DP
Brenntag : statement on ISS’ voting recommendation dated 26 May 2023
PU
Dpa-AFX Overview: COMPANIES of 05/26/2023 - 3:15 p.m.
DP
Shareholder advisor ISS also opposes Brenntag candidate for supervisory board
DP
Investor proposes two own candidates for Brenntag supervisory board seats
DP
DD: Brenntag SE : Notification and public disclosure of transactions by persons
EQ
Brenntag SE : Notification and public disclosure of transactions by persons
EQ
Evolva's Board of Directors intends to further strengthen its expertise at upcoming AGM and proposes, among others, the following agenda items:
EQ
Firmenich : Annual General Meeting 2021
PR
Firmenich International SA - Annual General Meeting 2021
PR
Evolva : shareholders approve all proposed resolutions at the Annual General Meeting 2021
AQ
Recipharm : Notice to attend the annual general meeting of Recipharm AB (publ)
AQ
Evolva : shareholders approve all proposed resolutions at the Annual General Meeting 2021
PU
Evolva : shareholders approve all proposed resolutions at the Annual General Meeting 2021
EQ
Evolva Holding SA Executive Elections At the Annual General Meeting, 2021
CI
Evolva : publishes agenda for 2021 Annual General Meeting
PU
Evolva : publishes agenda for 2021 Annual General Meeting
EQ
Recipharm : Notice of extraordinary general meeting in Recipharm AB (publ)
AQ
Firmenich Shareholders Endorse New 2025 Strategy and Re-Elect Directors
PR
Doreen Nowotne Elected Supervisory Board Chairperson of Brenntag AG / General Shareholders' Meeting Passes Resolution on Conversion to SE
PR
Moderna : Lonza picks Roche executive as CEO, ending year of turmoil at the top
RE
Evolva publishes agenda for 2020 Annual General Meeting
TE
Evolva announces changes to the Board of Directors and Management Team to support the delivery of strategic priorities
TE
Transcript : Lonza Group Ltd, Q1 2019 Earnings Call, Apr 18, 2019
European luxury stocks sparkle, Wirecard weighs on Dax
RE
Transcript : Lonza Group Ltd, 2018 Earnings Call, Jan 30, 2019
Lonza Announces Succession of CEO
TE
Lonza Achieved Another Excellent Full-Year Result in 2018 with 9% Organic Sales Growth and Strong Profitability Driven by Healthcare Businesses
TE
Lonza Group Ltd Announces CEO Changes with Effect from 1 March 2019
CI
Lonza : sells water care business for $630 million
RE
Lonza Further Strengthens Focus on Its Healthcare Continuum Strategy by Signing Agreement to Divest Water Care Business to Platinum Equity
TE
Transcript : Lonza Group Ltd, Q3 2018 Earnings Call, Oct 25, 2018
Lonza Continues Strong Momentum in Businesses Along the Healthcare Continuum in Q3 2018 and Confirms Positive Outlook for the Full Year
TE
Lonza's Capital Markets Day 2018 Outlines Sustainable Growth Plans Through Focus and Investment
TE
Transcript : Lonza Group Ltd, H1 2018 Earnings Call, Jul 25, 2018
Lonza Reports Strong Momentum with Organic Growth of 8% Sales and 11% CORE EBITDA in H1 2018
TE
Transcript : Lonza Group Ltd, Q1 2018 Earnings Call, May 04, 2018
Lonza Reports Positive Start to 2018 with Businesses Along the Healthcare Continuum as Growth Drivers
TE
Lonza : Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)
PU
Lonza Opens World’s Largest Dedicated Cell and-Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)
TE
Transcript : Lonza Group Ltd, 2017 Earnings Call, Jan 31, 2018
No results for this search
  1. Stock Market
  2. Advanced search
  3. Richard Ridinger
  4. News